ArticleCureus2024

Clinical Efficacy and Safety of Low-Dose Pemafibrate in Patients With Severe Renal Impairment: A Retrospective Study.

Hisato Shima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.